Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the 118th Congress, we have advocated for the reauthorization of and funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. Advocacy pertaining to youth and adolescent mental and behavioral health issues has included discussion of the reintroduction of legislative proposals such as: the Childrens Mental Health Infrastructure Act; the Helping Kids Cope Act (H.R. 2412); the Health Care Capacity for Pediatric Mental Health Act; the Kids Mental Health Now Act.
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have focused on the need to provide additional support for early career pediatric researchers through the planned reintroduction of the Pediatricians Accelerate Childhood Therapies (PACT) Act; inclusion of children within the All of Us research program, ARPA-H, and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance/pandemic preparedness, health IT and interoperability concerns to Congressional leaders.
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the reintroduction of the Accelerating Kids Access to Care Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children.
Duration: November 1, 2007
to
present
General Issues: Health Issues , Medical/Disease Research/Clinical Labs , Medicare/Medicaid , Defense
Spending: about $5,740,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2007: U.S. Senate, House of Representatives, Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Centers For Medicare and Medicaid Services (CMS), U.S. Senate,, Centers For Medicare and Medicaid Services (CMS),, White House Office, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Y
Y
Health and Human Services
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 30.
Original Filing: 301577541.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the 118th Congress, we have advocated for the reauthorization of and funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. Advocacy pertaining to youth and adolescent mental and behavioral health issues has included discussion of the reintroduction of legislative proposals such as: the Childrens Mental Health Infrastructure Act; the Helping Kids Cope Act (H.R. 2412); the Health Care Capacity for Pediatric Mental Health Act; the Kids Mental Health Now Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have focused on the need to provide additional support for early career pediatric researchers through the planned reintroduction of the Pediatricians Accelerate Childhood Therapies (PACT) Act; inclusion of children within the All of Us research program, ARPA-H, and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance/pandemic preparedness, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the reintroduction of the Accelerating Kids Access to Care Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
4th Quarter, 2023
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 24.
Original Filing: 301541709.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the 118th Congress, we have advocated for the reauthorization of and funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. Advocacy pertaining to youth and adolescent mental and behavioral health issues has included discussion of the reintroduction of legislative proposals such as: the Childrens Mental Health Infrastructure Act; the Helping Kids Cope Act (H.R. 2412); the Health Care Capacity for Pediatric Mental Health Act; the Kids Mental Health Now Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have focused on the need to provide additional support for early career pediatric researchers through the planned reintroduction of the Pediatricians Accelerate Childhood Therapies (PACT) Act; inclusion of children within the All of Us research program, ARPA-H, and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance/pandemic preparedness, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the reintroduction of the Accelerating Kids Access to Care Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
3rd Quarter, 2023
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 30, 2023.
Original Filing: 301518043.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the 118th Congress, we have advocated for the reauthorization of and funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. Advocacy pertaining to youth and adolescent mental and behavioral health issues has included discussion of the reintroduction of legislative proposals such as: the Childrens Mental Health Infrastructure Act; the Helping Kids Cope Act (H.R. 2412); the Health Care Capacity for Pediatric Mental Health Act; the Kids Mental Health Now Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have focused on the need to provide additional support for early career pediatric researchers through the planned reintroduction of the Pediatricians Accelerate Childhood Therapies (PACT) Act; inclusion of children within the All of Us research program, ARPA-H, and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance/pandemic preparedness, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the planned reintroduction of the Accelerating Kids Access to Care Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
2nd Quarter, 2023
CHILDREN'S HOSPITAL BOSTON amended a lobbying report for in-house lobbying in Q22023 on Aug. 21, 2023
Original Filing: 301495301.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the 118th Congress, we have advocated for the reauthorization of and funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. Advocacy pertaining to youth and adolescent mental and behavioral health issues has included discussion of the reintroduction of legislative proposals such as: the Childrens Mental Health Infrastructure Act; the Helping Kids Cope Act (H.R. 2412); the Health Care Capacity for Pediatric Mental Health Act; the Kids Mental Health Now Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have focused on the need to provide additional support for early career pediatric researchers through the planned reintroduction of the Pediatricians Accelerate Childhood Therapies (PACT) Act; inclusion of children within the All of Us research program, ARPA-H, and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance/pandemic preparedness, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the planned reintroduction of the Accelerating Kids Access to Care Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
2nd Quarter, 2023
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 24, 2023.
Original Filing: 301493345.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the 118th Congress, we have advocated for the reauthorization of and funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. Advocacy pertaining to youth and adolescent mental and behavioral health issues has included discussion of the reintroduction of legislative proposals such as: the Childrens Mental Health Infrastructure Act; the Helping Kids Cope Act (H.R. 2412); the Health Care Capacity for Pediatric Mental Health Act; the Kids Mental Health Now Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have focused on the need to provide additional support for early career pediatric researchers through the planned reintroduction of the Pediatricians Accelerate Childhood Therapies (PACT) Act; inclusion of children within the All of Us research program, ARPA-H, and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance/pandemic preparedness, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the planned reintroduction of the Accelerating Kids Access to Care Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
1st Quarter, 2023
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 25, 2023.
Original Filing: 301469203.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the 118th Congress, we have advocated for the reauthorization of and funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. Advocacy pertaining to youth and adolescent mental and behavioral health issues has included discussion of the reintroduction of legislative proposals such as: the Childrens Mental Health Infrastructure Act; the Helping Kids Cope Act (H.R. 2412); the Health Care Capacity for Pediatric Mental Health Act; the Kids Mental Health Now Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have focused on the need to provide additional support for early career pediatric researchers through the planned reintroduction of the Pediatricians Accelerate Childhood Therapies (PACT) Act; inclusion of children within the All of Us research program, ARPA-H, and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance/pandemic preparedness, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the planned reintroduction of the Accelerating Kids Access to Care Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
4th Quarter, 2022
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 20, 2023.
Original Filing: 301441797.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the 117th Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We advocated for H.R. 5131/S. 2762 the PedIatric Access to Critical Health Care (PATCH) Act. We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. Advocacy pertaining to youth and adolescent mental and behavioral health issues has included development of legislation proposals H.R. 7236 the Strengthen Kids Mental Health Now Act; H.R. 4943 the Childrens Mental Health Infrastructure Act; H.R. 4944 the Helping Kids Cope Act; S. 4472 the Health Care Capacity for Pediatric Mental Health Act; S. 4747 the Kids Mental Health Now Act and engagement with Senate Finance and Senate HELP processes including hearings.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have focused on the need to provide additional support for early career pediatric researchers as exemplified in the Pediatricians Accelerate Childhood Therapies (PACT) Act (S. 1357 and H.R. 3773); inclusion of children within the All of Us research program and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the Accelerating Kids Access to Care Act (S. 1544 and H.R. 3089) and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
3rd Quarter, 2022
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 27, 2022.
Original Filing: 301421259.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. We continue to advocate along these priorities through the Strengthen Kids Mental Health Now Act (H.R. 7236) and Health Care Capacity for Pediatric Mental Health Act (S.4472). Advocacy pertaining to youth and adolescent mental and behavioral health issues has included development of legislation proposals and engagement with Senate Finance and Senate HELP processes including hearings.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have also focused on Department of Defense (DoD) support for medical research. We have focused on the need to provide additional support for early career pediatric researchers as exemplified in the Pediatricians Accelerate Childhood Therapies (PACT) Act (S. 1357 and H.R. 3773); inclusion of children within the All of Us research program and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the Accelerating Kids Access to Care Act (S. 1544 and H.R. 3089) and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children. We also continue to advocate for increased payment rates for pediatric mental health services covered by Medicaid through the above mentioned, Strengthen Kids Mental Health Now Act (H.R. 7236) and the Investing in Kids Mental Health Now Act (S. 4747)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
3rd Quarter, 2022
CHILDREN'S HOSPITAL BOSTON amended a lobbying report for in-house lobbying in Q32022 on Oct. 27, 2022
Original Filing: 301421260.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. We continue to advocate along these priorities through the Strengthen Kids Mental Health Now Act (H.R. 7236) and Health Care Capacity for Pediatric Mental Health Act (S.4472). Advocacy pertaining to youth and adolescent mental and behavioral health issues has included development of legislation proposals and engagement with Senate Finance and Senate HELP processes including hearings.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have also focused on Department of Defense (DoD) support for medical research. We have focused on the need to provide additional support for early career pediatric researchers as exemplified in the Pediatricians Accelerate Childhood Therapies (PACT) Act (S. 1357 and H.R. 3773); inclusion of children within the All of Us research program and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the Accelerating Kids Access to Care Act (S. 1544 and H.R. 3089) and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children. We also continue to advocate for increased payment rates for pediatric mental health services covered by Medicaid through the above mentioned, Strengthen Kids Mental Health Now Act (H.R. 7236) and the Investing in Kids Mental Health Now Act (S. 4747)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
2nd Quarter, 2022
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 19, 2022.
Original Filing: 301387321.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. Advocacy pertaining to youth and adolescent mental and behavioral heath issues has included development of legislation proposals and engagement with Senate Finance and Sente HELP processes including hearings.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have also focused on Department of Defense (DoD) support for medical research. We have focused on the need to provide additional support for early career pediatric researchers as exemplified in the Pediatricians Accelerate Childhood Therapies (PACT) Act (S. 1357 and H.R. 3773); inclusion of children within the All of Us research program and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the Accelerating Kids Access to Care Act (S. 1544 and H.R. 3089) and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
1st Quarter, 2022
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 21, 2022.
Original Filing: 301372924.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. Advocacy pertaining to youth and adolescent mental and behavioral heath issues has included development of legislation proposals and engagement with Senate Finance and Sente HELP processes including hearings.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have also focused on Department of Defense (DoD) support for medical research. We have focused on the need to provide additional support for early career pediatric researchers as exemplified in the Pediatricians Accelerate Childhood Therapies (PACT) Act (S. 1357 and H.R. 3773); inclusion of children within the All of Us research program and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the Accelerating Kids Access to Care Act (S. 1544 and H.R. 3089) and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
4th Quarter, 2021
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 31, 2022.
Original Filing: 301340358.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. In the most recent quarters, we have worked actively to assure that health care funding for COVID response includes pediatric providers and children's hospitals. During Q4 of 2021, Boston Childrens has also been engaging with Congressional offices, the Office of the Secretary of HHS and the Health Resources and Services Administration (HRSA) pertaining to distributions from the Provider Relief Fund (PRF).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have also focused on Department of Defense (DoD) support for medical research. We have focused on the need to provide additional support for early career pediatric researchers as exemplified in the Pediatricians Accelerate Childhood Therapies (PACT) Act (S. 1357 and H.R. 3773); inclusion of children within the All of Us research program and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the Accelerating Kids Access to Care Act (S. 1544 and H.R. 3089) and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
3rd Quarter, 2021
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 27, 2021.
Original Filing: 301316423.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. In the most recent quarters, we have worked actively to assure that health care funding for COVID response includes pediatric providers and children's hospitals. During Q3 of 2021, Boston Childrens has also been engaging with Congressional offices, the Office of the Secretary of HHS and the Health Resources and Services Administration (HRSA) pertaining to distributions from the Provider Relief Fund (PRF).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have also focused on Department of Defense (DoD) support for medical research. We have focused on the need to provide additional support for early career pediatric researchers as exemplified in the Pediatricians Accelerate Childhood Therapies (PACT) Act (S. 1357 and H.R. 3773); inclusion of children within the All of Us research program and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the Accelerating Kids Access to Care Act (S. 1544 and H.R. 3089) and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
2nd Quarter, 2021
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 21, 2021.
Original Filing: 301292118.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. In the most recent quarters, we have worked actively to assure that health care funding for COVID response includes pediatric providers and children's hospitals. During Q2 of 2021, Boston Childrens has also been engaging with Congressional offices, the Office of the Secretary of HHS and the Health Resources and Services Administration (HRSA) pertaining to distributions from the Provider Relief Fund (PRF).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have also focused on Department of Defense (DoD) support for medical research. We have focused on the need to provide additional support for early career pediatric researchers as exemplified in the Pediatricians Accelerate Childhood Therapies (PACT) Act (S. 1357 and H.R. 3773); inclusion of children within the All of Us research program and the 21st Century Cures 2.0. Our informatics research program has provided information on disease surveillance, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the Accelerating Kids Access to Care Act (S. 1544 and H.R. 3089) and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
1st Quarter, 2021
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 27, 2021.
Original Filing: 301269652.xml
Lobbying Issues
Boston Children's Hospital focuses on pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. We have also discussed the escalating mental and behavioral health challenges among youth and policy solutions in the areas of the pediatric mental health delivery system, workforce and infrastructure. In the most recent quarters, we have worked actively to assure that health care funding for COVID response includes pediatric providers and children's hospitals. During Q1 of 2021, Boston Childrens has also been engaging with Congressional offices and the Health Resources and Services Administration (HRSA) pertaining to distributions from the Provider Relief Fund (PRF).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health Resources & Services Administration (HRSA)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have also focused on Department of Defense (DoD) support for medical research. We have focused on the need to provide additional support for early career pediatric researchers as exemplified in the Pediatricians Accelerate Childhood Therapies (PACT) Act. Our informatics research program has provided information on disease surveillance, health IT and interoperability concerns to Congressional leaders
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Boston Children's Hospital focuses on child health access especially with respect to the Medicaid and CHIP programs. In the current Congress, we have sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have advocated for policies that enable complex pediatric patients to travel across state lines through the Accelerating Kids Access to Care Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2020
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 25, 2021.
Original Filing: 301246655.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have sought to insure that complex pediatric patients can travel across state lines through the Accelerating Kids Access to Care Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children. We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. In the most recent quarters, we have worked actively to assure that health care funding for COVID response includes pediatric providers and children's hospitals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have focused on the need to provide additional support for early career pediatric researchers. Our informatics research program has provided information on disease surveillance, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2020
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 26, 2020.
Original Filing: 301225295.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have sought to insure that complex pediatric patients can travel across state lines through the Accelerating Kids Access to Care Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children. We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. In the most recent quarters, we have worked actively to assure that health care funding for COVID response includes pediatric providers and children's hospitals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have focused on the need to provide additional support for early career pediatric researchers. Our informatics research program has provided information on disease surveillance, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2020
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 21, 2020.
Original Filing: 301203063.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have sought to insure that complex pediatric patients can travel across state lines through the ACE Kids Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children. We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. In the most recent quarter, we have worked actively to assure that health care funding for COVID response includes pediatric providers and children's hospitals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have focused on the need to provide additional support for early career pediatric researchers. Our informatics research program has provided information on disease surveillance, health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2020
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 21, 2020.
Original Filing: 301180500.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that children's' access to care through the Medicaid and CHIP programs is adequately funded. We have sought to insure that complex pediatric patients can travel across state lines through the ACE Kids Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children. We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have focused on the need to provide additional support for early career pediatric researchers. Our informatics research program has provided information on health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2019
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 22, 2020.
Original Filing: 301130014.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that ACA repeal and replace efforts do not threaten children's' access to care. We have sought to insure that complex pediatric patients can travel across state lines through the ACE Kids Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children. We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have focused on the need to provide additional support for early career pediatric researchers. Our informatics research program has provided information on health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2019
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 22, 2019.
Original Filing: 301079698.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that ACA repeal and replace efforts do not threaten children's' access to care. We have sought to insure that complex pediatric patients can travel across state lines through the ACE Kids Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children. We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. We have focused on the need to provide additional support for early career pediatric researchers. Our informatics research program has provided information on health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2019
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 19, 2019.
Original Filing: 301051303.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that ACA repeal and replace efforts do not threaten children's' access to care. We have sought to insure that complex pediatric patients can travel across state lines through the ACE Kids Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children. We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. Our informatics research program has provided information on health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2019
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 23, 2019.
Original Filing: 301039013.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that ACA repeal and replace efforts do not threaten children's' access to care. We have sought to insure that complex pediatric patients can travel across state lines through the ACE Kids Act and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children. We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. Our informatics research program has provided information on health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2018
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 23, 2019.
Original Filing: 301018330.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for reauthorization and funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that ACA repeal and replace efforts do not threaten children's' access to care. We have sought to insure that complex pediatric patients can travel across state lines through the ACE Kids Act (S428) and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children (S2415). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. In this calendar year, we opposed Medicaid cuts included in the American Health Care Recovery Act, the Better Care Reconciliation Act and the Graham-Cassidy legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. Our informatics research program has provided information on health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2018
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 29, 2018.
Original Filing: 300999497.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for reauthorization and funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that ACA repeal and replace efforts do not threaten children's' access to care. We have sought to insure that complex pediatric patients can travel across state lines through the ACE Kids Act (S428) and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children (S2415). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. In this calendar year, we opposed Medicaid cuts included in the American Health Care Recovery Act, the Better Care Reconciliation Act and the Graham-Cassidy legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. Our informatics research program has provided information on health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2018
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 24, 2018.
Original Filing: 300979325.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for reauthorization of the Children's Health Insurance Program (CHIP)and for reauthorization and funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that ACA repeal and replace efforts do not threaten children's' access to care. We have sought to insure that complex pediatric patients can travel across state lines through the ACE Kids Act (S428) and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children (S2415). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. In this calendar year, we opposed Medicaid cuts included in the American Health Care Recovery Act, the Better Care Reconciliation Act and the Graham-Cassidy legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. Our informatics research program has provided information on health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2018
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 30, 2018.
Original Filing: 300959430.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for reauthorization of the Children's Health Insurance Program (CHIP)and for reauthorization and funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that ACA repeal and replace efforts do not threaten children's' access to care. We have sought to insure that complex pediatric patients can travel across state lines through the ACE Kids Act (S428) and have been actively involved in efforts to simplify screening and enrollment for out of state providers treating these children (S2415). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. In this calendar year, we opposed Medicaid cuts included in the American Health Care Recovery Act, the Better Care Reconciliation Act and the Graham-Cassidy legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. Our informatics research program has provided information on health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2017
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 23, 2018.
Original Filing: 300937918.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for reauthroization of the Children's Health Insurance Program (CHIP)and for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that ACA repeal and replace efforts do not threaten children's' access to care. We have sought to insure that complex pediatric patients can travel across state lines through the ACE Kids Act (S428). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. In this calendar year, we opposed Medicaid cuts included in the American Health Care Recovery Act, the Better Care Reconciliation Act and the Graham-Cassidy legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. Our informatics research program has provided information on health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2017
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 20, 2017.
Original Filing: 300915289.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that ACA repeal and replace efforts do not threaten children's' access to care. We have sought to insure that complex pediatric patients can travel across state lines through the ACE Kids Act (S428). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. In this calendar year, we opposed Medicaid cuts included in the American Health Care Recovery Act, the Better Care Reconciliation Act and the Graham-Cassidy legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. Our informatics research program has provided information on health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2017
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 31, 2017.
Original Filing: 300898814.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that ACA repeal and replace efforts do not threaten children's' access to care. We have sought to insure that complex pediatric patients can travel across state lines through the ACE Kids Act (S428). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns. In this period, we opposed Medicaid cuts included in the American Health Care Recovery Act and the Better Care Reconciliation Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. Our informatics research program has provided information on health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2017
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on May 1, 2017.
Original Filing: 300879469.xml
Lobbying Issues
Boston Children's Hospital focuses on child health access (Medicaid/CHIP), pediatric workforce education, and public health issues impacting children. In the current Congress, we have advocated for funding through the appropriations process for the Children's Hospital Graduate Medical Education program (CHGME), and sought to insure that ACA repeal and replace efforts do not threaten children's' access to care. We have sought to insure that complex pediatric patients can travel across state lines through the ACE Kids Act (S428). We have also provided information on the impact of opioid abuse on adolescents and treatment approaches addressing these concerns.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Boston Children's Hospital advocates for medical research funding generally (eg NIH) and to assure an emphasis on pediatric research issues and concerns. In the current Congress, we have sought increases in the overall NIH appropriation level, and worked to assure better coordination across NIH institutes for pediatric initiatives. Our informatics research program has provided information on health IT and interoperability concerns to Congressional leaders.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2016
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 20, 2017.
Original Filing: 300853508.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric quality measurement, graduate medical education. H.R.546/S. 298 - ACE Kids Act of 2015. Suggested improvements to out of state provider screening and enrollment processes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research networks, health IT research initiatives, and specific disease areas.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2016
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 20, 2016.
Original Filing: 300835615.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric quality measurement, graduate medical education. H.R.546/S. 298 - ACE Kids Act of 2015. Suggested improvements to out of state provider screening and enrollment processes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research networks, and specific disease areas.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2016
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 21, 2016.
Original Filing: 300822143.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric quality measurement, graduate medical education. H.R.546/S. 298 - ACE Kids Act of 2015. Suggested improvements to out of state provider screening and enrollment processes.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research networks, and specific disease areas.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2016
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 22, 2016.
Original Filing: 300804136.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric quality measurement, graduate medical education. H.R.546/S. 298 - ACE Kids Act of 2015.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research networks, and specific disease areas.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2015
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 20, 2016.
Original Filing: 300783034.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric quality measurement, graduate medical education. H.R.546/S. 298 - ACE Kids Act of 2015.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research networks, and specific disease areas.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2015
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 20, 2015.
Original Filing: 300763749.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric quality measurement, graduate medical education. H.R.546/S. 298 - ACE Kids Act of 2015.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research networks, and specific disease areas.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2015
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 21, 2015.
Original Filing: 300747103.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric quality measurement, graduate medical education. H.R.546/S. 298 - ACE Kids Act of 2015.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research networks, and specific disease areas.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2015
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 22, 2015.
Original Filing: 300728552.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric quality measurement, graduate medical education.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2014
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 20, 2015.
Original Filing: 300705976.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric quality measurement, graduate medical education.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2014
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 20, 2014.
Original Filing: 300685647.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric quality measurement, graduate medical education.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2014
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 21, 2014.
Original Filing: 300665923.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric quality measurement, graduate medical education.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2014
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 23, 2014.
Original Filing: 300649886.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric quality measurement, graduate medical education.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2013
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 21, 2014.
Original Filing: 300624773.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric quality measurement, graduate medical education.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS),
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2013
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 18, 2013.
Original Filing: 300600518.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric pharmacy regulation, graduate medical education.
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2013
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 19, 2013.
Original Filing: 300578562.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric pharmacy regulation, graduate medical education.
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2013
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 17, 2013.
Original Filing: 300551356.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, pediatric pharmacy regulation, graduate medical education.
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2012
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 18, 2013.
Original Filing: 300535183.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, graduate medical education.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2012
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 19, 2012.
Original Filing: 300514657.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, graduate medical education.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS),
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2012
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 17, 2012.
Original Filing: 300485921.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, graduate medical education, pediatric drug shortages.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS),
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2012
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 20, 2012.
Original Filing: 300472279.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, graduate medical education.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS),
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2011
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 20, 2012.
Original Filing: 300446231.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, graduate medical education.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) White House Office
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2011
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 20, 2011.
Original Filing: 300422571.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, graduate medical education.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) White House Office
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2011
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 15, 2011.
Original Filing: 300390437.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, Medicaid and CHIP coverage, graduate medical education.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) White House Office
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2011
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 20, 2011.
Original Filing: 300373639.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, graduate medical education, discount drug purchasing.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) White House Office
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2010
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 14, 2011.
Original Filing: 300338896.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, graduate medical education, discount drug purchasing.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2010
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 19, 2010.
Original Filing: 300318234.xml
Lobbying Issues
Pediatric and child health issues in health care reform implementation, graduate medical education, discount drug purchasing.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2010
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 19, 2010.
Original Filing: 300291973.xml
Lobbying Issues
Pediatric/child health issues in health reform, medicaid funding, pharmacy coverage (340B), mental health coverage and access for children
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
Lobbying Issues
Appropriations request for tissue engineering/angiogenesis project
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Pediatric research issues and funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2010
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 13, 2010.
Original Filing: 300257355.xml
Lobbying Issues
Federal health reform legislation, issues related to child health coverage and pediatric providers, pediatric training issues. Appropriations request for school-based child mental health initiative.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Pediatric clinical and translational research, NIH funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Appropriations request for angiogenesis and tissue engineering research
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2009
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 19, 2010.
Original Filing: 300236005.xml
Lobbying Issues
Health care issues impacting children and child health including issues involved in the federal health refrom bills.
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office Health & Human Services - Dept of (HHS)
Lobbying Issues
Biomedical research issues affecting children.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2009
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 20, 2009.
Original Filing: 300216077.xml
Lobbying Issues
Health care reform issues, graduate medical education, pediatric research
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medical research appropriations request
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Pediatric research and research funding
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2009
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 15, 2009.
Original Filing: 300182715.xml
Lobbying Issues
Health care reform issues, graduate medical education, pediatric research
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medical research appropriations request
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 17, 2009.
Original Filing: 300154940.xml
Lobbying Issues
SCHIP reauthorization, health IT, health care reform, medical research funding in HHS and Dept of Defense appropriations request, Children's Hospitals GME
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2008
In Q4, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Jan. 12, 2009.
Original Filing: 300115471.xml
Lobbying Issues
SCHIP reauthorization, health IT legislation, health care reform issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2008
In Q3, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on Oct. 13, 2008.
Original Filing: 300090512.xml
Lobbying Issues
Pediatric graduate medical education, pediatric and biomedical research issues, child health coverage including Medicaid and SCHIP, and coverage for pediatric prescription medications.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
2nd Quarter, 2008
In Q2, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 15, 2008.
Original Filing: 300065636.xml
Lobbying Issues
Pediatric graduate medical education, pediatric and biomedical research issues, child health coverage including Medicaid and SCHIP, and coverage for pediatric prescription medications.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
1st Quarter, 2008
In Q1, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on April 16, 2008.
Original Filing: 300039595.xml
Lobbying Issues
Child health access (SCHIP reauthorization and related Medicaid issues), Graduate Medical Education, prescription medications for children, pediatric research issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
0th Quarter, 2007
In MM, CHILDREN'S HOSPITAL BOSTON had in-house lobbyists. The report was filed on July 31, 2007.
Original Filing: 200043311.xml
Lobbying Issues
General health issues related to children and providers of care to children.
Agencies Lobbied
Y
Y
Health and Human Services
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate